| Literature DB >> 31933628 |
A Akbas1, H Bakir2, M F Dasiran2, H Dagmura2, E Daldal2, Z Ozsoy2, Z Ozmen3, O Demir4, I Okan2.
Abstract
AIM/Entities:
Year: 2019 PMID: 31933628 PMCID: PMC6942854 DOI: 10.1155/2019/2492097
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
Demographic data and results of colonoscopy and histopathological evaluation of the patients.
| Group I | Group II | Total ( | ||
|---|---|---|---|---|
| Female | 23 | 19 | 42 (36.2%) | |
| Male | 41 | 33 | 74 (63.8%) | |
| Age (years) | 62.23 ± 14.72 | 65.08 ± 12.67 | ||
| Colonoscopic-histopathological evaluation | ( | ( | ||
| Colonoscopy with no finding | 27 | — | 27 (23.2%) | |
| Benign | Polyps | 22 | — | 37 (31.9%) |
| Colitis | 10 | — | ||
| Diverticulum | 5 | — | ||
| Malign | Adenocarcinoma | — | 51 | 52 (44.8%) |
| Lymphoma | — | 1 | ||
| Total ( | 64 | 52 | 116 | |
Comparison of the two groups.
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Group I | Group II |
| OR | 95% CI (min–max) |
| |
| Number ( | 64 | 52 | ||||
| Age (years) | 62.23 ± 14.72 | 65.08 ± 12.67 | 0.27 | 0.993 | 0.948-1.041 | 0.778 |
| Albumin (g/dl) | 3.95 ± 0.76 | 3.41 ± 0.7 | <0.001 | 0.963 | 0.361-2.57 | 0.940 |
| CWT (mm) | 9.43 ± 3.89 | 16.21 ± 10.3 | <0.001 | 1.182 | 1.036-1.348 | 0.013 |
| MPV (fL) | 7.2 ± 1.14 | 8.77 ± 1.97 | <0.001 | 1.851 | 1.13-3.032 | 0.014 |
| Hb (g/dl) | 12.99 ± 1.93 | 10.82 ± 1.7 | <0.001 | 0.566 | 0.35-0.916 | 0.021 |
| NLR | 2.11 ± 1.13 | 5.49 ± 3.7 | <0.001 | 1.944 | 0.991-3.813 | 0.043 |
| PLR | 119.88 ± 65.34 | 266.11 ± 202.76 | <0.001 | 0.996 | 0.983-1.01 | 0.608 |
OR: odds ratio; CWT: colon wall thickness; Hb: hemoglobin; MPV: mean platelet volume; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio.
Figure 1Receiver operating characteristic (ROC) curve analyses of significant parameters for the diagnosis of colon cancer. CWT: colon wall thickness; Hb: hemoglobin; MPV: mean platelet volume; NLR: neutrophil-to-lymphocyte ratio.
The results of ROC analysis.
| Variable | Cutoff value | AUC | 95% CI | Sensitivity | Specificity |
|
|---|---|---|---|---|---|---|
| CWT | >9 | 0.802 | 0.718-0.871 | 0.827 | 0.656 | <0.001 |
| Hb (g/dl) | ≤12.4 | 0.800 | 0.716-0.869 | 0.865 | 0.656 | <0.001 |
| NLR | >3.06 | 0.840 | 0.760-0.901 | 0.750 | 0.875 | <0.001 |
| MPV (fL) | >8.09 | 0.732 | 0.641-0.811 | 0.577 | 0.839 | <0.001 |
AUC: area under the curve; OR: odds ratio; CWT: colon wall thickness; Hb: hemoglobin; MPV: mean platelet volume; NLR: neutrophil-to-lymphocyte ratio.
Figure 2Management tool for colon wall thickening (CWT) to neoplasia with high positive predictive value.